-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Jutta Beier
Drug Evaluation: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Developing a National Network for Clinical Research: The NIHR Medicines for Children Research Network (MCRN)
Gemma L Saint, Vanessa Poustie, Rosalind L Smyth
Research Update: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation